Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and postoperative sleep quality, cortisol, 5-HT, hypocretin
ChiCTR2100051598Phase 4Not yet recruiting
- Sponsor
- Bethune International Peace Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in sleep disorder (2 arms), sponsored by Bethune International Peace Hospital. Primary endpoint: Postoperative sleep quality. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2100051598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051598.